Long-term use of botulinum toxin type A in children with cerebral palsy: treatment consistency.

[1]  P. Grimaud.  [Cerebral palsy]. , 1972, Pediatrie.

[2]  L. A. Koman,et al.  Management of Cerebral Palsy with Botulinum‐A Toxin: Preliminary Investigation , 1993, Journal of pediatric orthopedics.

[3]  N. Bathien,et al.  Botulinum antibodies in dystonic patients treated with type A botulinum toxin , 1993, Neurology.

[4]  S Fahn,et al.  Development of resistance to botulinum toxin type A in patients with torticollis , 2004, Movement disorders : official journal of the Movement Disorder Society.

[5]  A P Cosgrove,et al.  BOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER LIMB IN CEREBRAL PALSY , 1994, Developmental medicine and child neurology.

[6]  L. A. Koman,et al.  Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. , 1994, Journal of pediatric orthopedics.

[7]  R. Calderón-González,et al.  Botulinum toxin A in management of cerebral palsy. , 1994, Pediatric neurology.

[8]  W. Kahle.  The case against routine metal removal. , 1994, Journal of pediatric orthopedics.

[9]  Imaging back pain , 1995, Neurology.

[10]  K. Schwartz,et al.  Response and immunoresistance to botulinum toxin injections , 1995, Neurology.

[11]  J. Carruthers,et al.  Botulinum Toxin A , 2023, Reactions Weekly.

[12]  R. Palisano,et al.  Development and reliability of a system to classify gross motor function in children with cerebral palsy , 1997, Developmental medicine and child neurology.

[13]  K. Wohlfarth,et al.  Botulinum A Toxin Therapy: Neutralizing and Nonneutralizing Antibodies—Therapeutic Consequences , 1997, Experimental Neurology.

[14]  V. Wong,et al.  Use of botulinum toxin injection in 17 children with spastic cerebral palsy. , 1998, Pediatric neurology.

[15]  R. Boyd,et al.  Medium‐term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy , 1999 .

[16]  M. Delgado.  The use of botulinum toxin type A in children with cerebral palsy: a retrospective study , 1999 .

[17]  M. Massin,et al.  Role of exercise testing in the functional assessment of cerebral palsy children after botulinum A toxin injection. , 1999, Journal of pediatric orthopedics.

[18]  I. Jonkers,et al.  Botulinum toxin type A treatment of cerebral palsy: an integrated approach , 1999 .

[19]  A. Suputtitada.  Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A: preliminary report. , 2000, American journal of physical medicine & rehabilitation.

[20]  R. Boyd,et al.  Biomechanical transformation of the gastroc‐soleus muscle with botulinum toxin A in children with cerebral palsy , 2000, Developmental medicine and child neurology.

[21]  L. A. Koman,et al.  Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Lower Extremity Spasticity in Cerebral Palsy: A Randomized, Double-blind, Placebo-controlled Trial , 2000 .

[22]  C. Cans.  Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers , 2000, Developmental medicine and child neurology.

[23]  B. Bhakta,et al.  Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy , 2000, Archives of disease in childhood.

[24]  S. Hesse,et al.  Lower limb muscle activity in ambulatory children with cerebral palsy before and after the treatment with Botulinum toxin A. , 2000, Restorative neurology and neuroscience.

[25]  H. Graham.  Botulinum toxin A in cerebral palsy: functional outcomes. , 2000, The Journal of pediatrics.

[26]  D. Gaebler-Spira,et al.  Use of Botulinum Toxin Type A in Pediatric Patients With Cerebral Palsy: A Three-Center Retrospective Chart Review , 2001, Journal of child neurology.

[27]  I. Jonkers,et al.  A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures , 2001, European journal of neurology.

[28]  A. Cosgrove,et al.  Safety profile and efficacy of botulinum toxin A (Dysporta) in children with muscle spasticity , 2001, Developmental medicine and child neurology.

[29]  M. Galli,et al.  Short-term effects of "botulinum toxin a" as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint. , 2001, Functional neurology.

[30]  R. Boyd,et al.  Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review , 2001, European journal of neurology.

[31]  Die Therapie spastischer Bewegungsstörungen im Kindesalter mit Botulinumtoxin A , 2001 .

[32]  F. Heinen,et al.  Medium‐term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1‐year follow‐up using gross motor function measure , 2001, European journal of neurology.

[33]  L. A. Koman,et al.  Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. , 2001, Pediatrics.

[34]  L. Doederlein,et al.  Repeated Botulinum Toxin A Injections in the Treatment of Spastic Equinus Foot , 2002, Clinical orthopaedics and related research.

[35]  O. Suchowersky,et al.  Long‐term efficacy of botulinum toxin A in treatment of various movement disorders over a 10‐year period , 2002, Movement disorders : official journal of the Movement Disorder Society.

[36]  N. Quinn,et al.  Antibody-Induced Botulinum Toxin Therapy Failure: Can It Be Overcome by Increased Botulinum Toxin Doses? , 2002, European Neurology.

[37]  D. Weinberger,et al.  Quantitative changes in botulinum toxin a treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm. , 2003, American journal of ophthalmology.

[38]  Rajesh Balkrishnan,et al.  Spasticity Associated with Cerebral Palsy in Children , 2003, Paediatric drugs.

[39]  G. Serdaroğlu,et al.  The use of botulinum toxin type A treatment in children with spasticity. , 2003, Pediatric neurology.

[40]  S. Ristanis,et al.  Botulinum A toxin for treatment of lower limb spasticity in cerebral palsyGait analysis in 49 patients , 2003, Acta orthopaedica Scandinavica.

[41]  J. Sławek,et al.  Functional improvement in cerebral palsy patients treated with botulinum toxin A injections – preliminary results , 2003, European journal of neurology.

[42]  F. Heinen,et al.  Clinical impact of antibody formation to botulinum toxin A in children , 2004, Annals of neurology.

[43]  M. Salem,et al.  The effect of botulinum toxin type-A injection on spasticity, range of motion and gait patterns in children with spastic diplegic cerebral palsy: an Egyptian study , 2004, International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.

[44]  La Koman,et al.  Seminar. Cerebral palsy , 2004 .

[45]  G. Molenaers,et al.  Botulinumtoxin A bei der Behandlung der infantilen Zerebralparese , 2004, Der Orthopäde.

[46]  Florian Heinen,et al.  Use of botulinum toxin in pediatric spasticity (cerebral palsy) , 2004, Movement disorders : official journal of the Movement Disorder Society.

[47]  A. Ceballos-Baumann,et al.  Long‐term follow‐up of cervical dystonia patients treated with botulinum toxin A , 2004, Movement disorders : official journal of the Movement Disorder Society.

[48]  K. Desloovere,et al.  [Botulinum toxin A in the treatment of infantile cerebral palsy. Taking into account multilevel, integrated treatment]. , 2004, Der Orthopade.

[49]  J. Jankovic,et al.  Long‐term botulinum toxin efficacy, safety, and immunogenicity , 2005, Movement disorders : official journal of the Movement Disorder Society.

[50]  A. Marchetti,et al.  Longitudinal assessment of the dose consistency of botulinum toxin type a (BOTOX®) for cervical dystonia , 2005, Advances in therapy.

[51]  E. M. Goldstein.  Safety of High-Dose Botulinum Toxin Type A Therapy for the Treatment of Pediatric Spasticity , 2006, Journal of child neurology.

[52]  F. Heinen,et al.  When it comes to botulinum toxin, children and adults are not the same: Multimuscle option for children with cerebral palsy , 2006, Movement disorders : official journal of the Movement Disorder Society.

[53]  Kaat Desloovere,et al.  The effects of quantitative gait assessment and botulinum toxin a on musculoskeletal surgery in children with cerebral palsy. , 2006, The Journal of bone and joint surgery. American volume.

[54]  Why do children with cerebral palsy discontinue therapy with botulinum toxin A? , 2007, Developmental medicine and child neurology.

[55]  K. Desloovere,et al.  Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy , 2006, Developmental medicine and child neurology.